An investigation by the British Medical Journal into the top-selling diabetes drug rosiglitazone (Avandia) raises concerns about its safety and the whole system by which drugs are evaluated, regulated, and promoted around the world.
Results 1 to 1 of 1
MEDiscuss • Medical News • Report on top-selling diabetes drug raises concerns about the drug regulatory system
- September 7th, 2010 #1Bot
- Member since
- Jul 2007
- Posts
- 20,760
Report on top-selling diabetes drug raises concerns about the drug regulatory system
QuoteRelated Posts
-
Pediatric brain tumors: Regulatory protein represents potential drug target
By MedBot in forum Medical NewsReplies: 0Last Post: September 19th, 2011, 07:00 PM -
Fading ability to taste iron raises health concerns for people over age 50
By MedBot in forum Medical NewsReplies: 0Last Post: August 10th, 2011, 04:06 PM -
FDA should invest in developing a new regulatory framework to replace flawed 510(k) medical device clearance process: Report
By MedBot in forum Medical NewsReplies: 0Last Post: August 1st, 2011, 10:15 PM -
Experimental drug raises 'good' cholesterol, may help control diabetes
By MedBot in forum Medical NewsReplies: 0Last Post: July 18th, 2011, 10:13 PM -
Investigation raises concerns about the post-approval surveillance of medical devices
By MedBot in forum Medical NewsReplies: 0Last Post: November 3rd, 2010, 12:38 AM
Posting Permissions
The information provided on this site is meant to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
All times are GMT. The time now is 03:55 AM.